Emerging Infectious Disease ISSN: 1080-6059

Increase in Pneumococcus Macrolide Resistance, United States

Stephen G. Jenkins

and David J. Farrell

Author affiliations: Weill Cornell Medical College, New York, NY, USA (S.G. Jenkins); Quotient Bioresearch Ltd, London, UK (D.J. Farrell)

Main Article

Figure 1

Increased prevalence of erythromycin-resistant Streptococcus pneumoniae (ERSP), by age group, Prospective Resistant Organism Tracking and Epidemiology for the Ketolide Telithromycin, United States surveillance study, years 1–6 (2000–2006).

Figure 1. . Increased prevalence of erythromycin-resistant Streptococcus pneumoniae (ERSP), by age group, Prospective Resistant Organism Tracking and Epidemiology for the Ketolide Telithromycin, United States surveillance study, years 1–6 (2000–2006).

Main Article

Top of Page

The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.